Preparation method and application of metal oxide hybrid hollow polydopamine microspheres
By preparing hollow polydopamine microspheres hybridized with metal oxides, the problems of structural instability and insufficient responsiveness of polydopamine microspheres in the blood circulation process were solved, achieving specific release and efficient delivery of drugs, which is suitable for integrated tumor diagnosis and treatment.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- LUOYANG INST OF SCI & TECH
- Filing Date
- 2026-01-12
- Publication Date
- 2026-05-26
AI Technical Summary
Existing polydopamine microspheres, as drug carriers, have poor structural stability during blood circulation, are prone to swelling and rupture, leading to premature drug leakage, and lack tumor microenvironment responsiveness, resulting in nonspecific drug delivery and low drug loading.
Using sulfonated polystyrene microspheres as hard templates, metal ions and dopamine are adsorbed through electrostatic interaction to form a metal oxide hybrid core-shell structure. Hollow polydopamine microspheres with metal oxide hybrids are prepared by hydrothermal reaction and dialysis technology to enhance structural stability and endow the tumor microenvironment with responsiveness.
It achieves specific release and efficient delivery of drugs, avoids toxic side effects caused by premature drug release, improves drug loading and delivery efficiency, and is suitable for the integrated diagnosis and treatment of tumors.
Smart Images

Figure CN122075432A_ABST